Q2 2016 Cloud

Q2 Pharmacovigilance and Drug Safety Conferences – What did you miss?

Q2 Pharmacovigilance and Drug Safety Conferences – What did you miss? Great industry conferences are often the result of a combination of factors: good planning, strong speakers, with real depth in expertise and a passion for their topic, and attendees/delegates with great questions.  When all three line up in one event, all participants gain tremendous value from the presentations and …

The Stem Cells Regenerative Medicine Congress is where experts like Mayo Clinic meet to network, learn from each other, and discuss the latest regenerative medicine strategies and technology.

How Mayo Clinic’s Center for Regenerative Medicine Biotrust is Facilitating the Translation of Regenerative Therapies

The Regenerative Medicine Biotrust (Biotrust) enables the Mayo Clinic Center for Regenerative Medicine to collect, process and store cells and other biospecimens from individual patients. As a patient’s own cells are often used as a starting point for regenerative therapies, having them readily available in the biotrust is critical. Any human cells or tissues with application to regenerative medicine and surgery are within the scope of the Biotrust. …

The Stem Cells Regenerative Medicine Congress is where experts like Russell Marians of LABS Inc meet to network, learn from each other, and discuss the latest stem cells strategies and technology.

LABS Inc on ensuring successful scale-up manufacturing

We were glad to have Russell Marians, Senior Scientist and Manager of Molecular and Cellular Biology at LABS Inc., present at the Stem Cells & Regenerative Medicine Congress in 2013. You can now download his presentation slides and video from the event, where he addresses how a winning assay development strategy is critical to ensure successful scale-up manufacturing. Download the presentation …

Stem Cells Regenerative Medicine Congress is where experts like Neuralstem's Richard Garr meet to network, learn from each other, and discuss the latest stem cell strategies and technology.

Neuralstem’s Richard Garr on Optimizing and Increasing Titer

We were excited to have Richard Garr, Chief Executive Officer of Neuralstem, at last year’s Stem Cells Regenerative Medicine Congress. Richard gave a presentation on optimizing and increasing titer in early stage clinical trials for an easier approval process as part of the event that focused on next generation approaches. Other speakers that participated in that section of the event …

Stem Cells USA is where experts like Scimitar Equity's Henry McCusker gather to network, learn from each other, and discuss the latest stem cells strategies and technology.

Scimitar Equity’s Henry McCusker at Stem Cells USA 2013

We were excited to have Scimitar Equity’s Founder and Director of Research Henry McCusker give the opening remarks at last year’s Stem Cells & Regenerative Medicine Congress USA. Henry not only opened up the conference, but also participated in a panel later on in the event. The panel session was titled “Capital formation strategies for stem cell and regenerative medicine …

Ebook: Top 20 Big Data projects in Pharma & Biotech – Part 2

    There are 5 main areas of Big Data investigation in real world outcomes by pharma today… Remote, mobile health – The use of mobile devices such as smart phones to gather data on treatment adherence, on-going patient care, predictive symptoms or adverse events and health outcomes Healthcare provider data – Collecting data from electronic medical records that includes …

Robin Geller, Baxter Healthcare Corporation, on the #Pharmacovigilance industry

Continuing with our series on the current pharmacovigilance industry we spoke with Robin Geller, Director of Risk Management and Safety Writing Global Pharmacovigilance, at Baxter Healthcare Corporation What is the biggest change that you are seeing in pharma's drug safety strategies at the moment? The continuing shift from submission of individual case reports to aggregate analysis, signal detection and risk …

Topics to be covered at #DrugSafety Europe

If you can't make our Drug Safety USA event taking place next week, why not check out our European event coming up in September? The brochure is due out in a few weeks but see below for a sneak preview of some of the presentations due to take place: In depth review of the new European pharmacovigilance legislation Operational implications …

Who has previously attended Drug Safety World?

  The World Drug Safety Congress Americas will provide you with the opportunity to meet and network with the big names in the industry. If you are thinking of attending but aren't sure who will be there, check out the list below of previous companies who have come to the event in the past.   If you are interested in …